Urinary Tract Infections

Key Points

• UTI includes lower tract disease (cystitis, urethritis) and upper tract disease (pyelonephritis).
• Persons assigned female at birth have higher risk, and approximately 8% of pregnant patients experience UTIs.
• Urine culture is definitive; urinalysis with white blood cells and nitrites strongly supports diagnosis.
• Older adults may present with atypical cues including confusion, but confusion alone is not diagnostic for UTI without supportive urinary/infectious findings.
• Pregnancy requires early culture screening and targeted antibiotic treatment to reduce preterm birth and low-birth-weight risk.
• Recurrence prevention teaching should include hydration, postcoital voiding, front-to-back wiping, and avoiding genital products that disrupt normal flora.

Pathophysiology

UTIs occur when microorganisms, most commonly bacteria, colonize the urinary tract and trigger mucosal inflammation. Lower urinary infections involve the bladder or urethra, while upper urinary infection reflects ascending spread to the kidneys with systemic illness risk.

Escherichia coli is the most common cause of cystitis and pyelonephritis. In pyelonephritis, bacterial ascent can progress from local inflammation to renal involvement (including renal pelvis, cortex, and medulla inflammation), increasing risk for severe complications such as abscess formation, acute renal injury, and sepsis.

Classification

• Lower UTI: Cystitis: Bladder infection with dysuria, frequency, suprapubic pain, and possible hematuria.
• Lower UTI: Noninfectious cystitis: Bladder inflammation from irritants such as chemotherapy-related or radiation exposure.
• Lower UTI: Urethritis: Urethral inflammation, often related to sexually-transmitted-infections; may present with dysuria, discharge, or pruritus.
• Interstitial cystitis: Chronic bladder pain syndrome with no known cause and no curative therapy.
• Upper UTI: Pyelonephritis: Kidney infection with fever, flank pain, nausea, or vomiting; complicated disease includes pregnancy and immunocompromise.
• Pregnancy-associated asymptomatic bacteriuria: Culture-positive bacteriuria without symptoms; generally treated in pregnancy to reduce pyelonephritis and adverse birth outcomes.

Nursing Assessment

NCLEX Focus

Priority questions often test which findings require escalation to upper UTI concern, especially fever with flank pain.

• Assess dysuria, urinary frequency, urgency, suprapubic pain, and urine changes (cloudiness, foul odor, or hematuria).
• Assess associated lower-tract symptom burden, including nocturia and incontinence, plus GI symptoms such as nausea or reduced appetite.
• Screen for upper-tract cues including fever, costovertebral tenderness, nausea, and vomiting.
• Assess for systemic-severity cues in suspected pyelonephritis, including chills, malaise/fatigue, tachycardia, blood-pressure instability, confusion, or increased respiratory rate.
• In older adults, treat new confusion or delirium as a high-priority possible UTI manifestation.
• In older adults, also watch for atypical cues such as reduced interaction, new incontinence, unusual sleepiness, reduced appetite, and frequent falls.
• Avoid diagnosing UTI from urinalysis alone in asymptomatic patients; asymptomatic bacteriuria often does not require antibiotics outside pregnancy-focused indications.
• Review risk factors: pregnancy, diabetes, urinary abnormalities, urinary retention from BPH or stones, catheter exposure, menopause-related flora changes, neurogenic bladder, and pelvic organ prolapse.
• For patients with an indwelling urinary catheter, urgently escalate fever 100.4 F (38 C) or higher, new mental-status change, chills, malodorous urine, and suprapubic or flank pain.
• Include recurrence and exposure risk checks such as prior UTI history, recent new sexual partner, age extremes, and structural outlet issues (for example prostate enlargement).
• Obtain and interpret urinalysis findings (white blood cells, nitrites, possible hematuria/proteinuria).
• Recognize urine dip testing as a common first-line screen before urinalysis/culture confirmation.
• Ensure urine culture collection when indicated and monitor for recurrent symptoms after treatment.
• For first uncomplicated lower UTI, recognize empiric treatment may begin without culture; prioritize cultures in recurrent, complicated, or hospital-associated risk settings.
• For MDR-risk cystitis profiles, review recent risk cues (recent inpatient stay, prior MDR gram-negative isolate, recent fluoroquinolone or broad-spectrum antibiotic exposure, or travel to high-MDR-prevalence regions) when supporting empiric antibiotic selection.
• For suspected pyelonephritis, trend blood tests including CBC, creatinine, BUN, and C-reactive protein; obtain blood cultures when systemic infection is suspected.
• For recurrent cystitis, anticipate additional evaluation such as bladder ultrasound, KUB/CT imaging, or cystoscopy for structural causes.
• For complicated pyelonephritis or poor response, anticipate renal imaging and occasional nuclear medicine studies to evaluate reduced function or scarring.

Nursing Interventions

• Support prompt collection of clean-catch urine using contamination-reduction technique and immediate transport.
• Reinforce medication adherence to full prescribed antimicrobial duration and monitor treatment response.
• Interpret urine culture context with the team: single-organism high colony count (commonly >100,000 CFU/mL) supports infection, while mixed growth often suggests collection contamination and may require repeat sampling.
• Educate on recurrence prevention: hydration, voiding before/after intercourse, front-to-back hygiene, regular complete emptying, and avoiding prolonged urine holding.
• Teach irritant reduction for recurrent symptoms (for example caffeine, alcohol, spicy foods, harsh perineal products, and tight/friction-prone garments).
• Teach symptom escalation cues for developing pyelonephritis (fever, flank or low back pain, nausea, vomiting).
• Escalate possible pyelonephritis when fever rises above about 101 F (38.3 C), especially with shaking chills and flank pain.
• For severe pyelonephritis, support hospitalization pathways for IV antibiotics, IV fluids, and close monitoring.
• Coordinate escalation when obstruction, renal abscess, or persistent systemic infection suggests definitive procedural or surgical control needs.
• In pregnancy, prioritize culture-based screening and treatment coordination per prenatal protocols.
• In pregnancy, support early urine-culture screening for asymptomatic bacteriuria and targeted 5-7 day antibiotic treatment when positive; with symptomatic episodes, support urinalysis/culture and follow-up testing strategy if symptoms recur.
• In pregnancy-associated pyelonephritis, prioritize initial inpatient management and completion of a full antibiotic course (commonly 14 days) per obstetric protocol.
• Escalate severe findings (fever, flank pain, persistent vomiting, or pregnancy with pyelonephritis) for higher-level care.
• Reinforce prevention detail for recurrent UTI risk reduction: prefer showers over baths and avoid douching, genital sprays, or powders that can alter local pH and flora.
• If an indwelling catheter is present, verify ongoing indication daily and remove promptly when criteria are no longer met.

Escalation Risk

Untreated or undertreated cystitis can progress to pyelonephritis and sepsis; delayed pyelonephritis control can also cause renal abscess or chronic kidney damage.

Pharmacology

Drug Class	Examples	Key Nursing Considerations
urinary-anti-infectives	Nitrofurantoin, TMP-SMX, fosfomycin tromethamine, methenamine hippurate	Confirm baseline urinalysis/culture status and screen contraindications by renal/hepatic function, age, pregnancy/lactation, and high-risk interaction profile.
antibiotics	TMP-SMX, cephalosporins, penicillins, fluoroquinolones, fosfomycin	Use culture-guided therapy when available and complete the full prescribed course.
antibiotics (nitrofurantoin)	Nitrofurantoin monohydrate/macrocrystals 100 mg twice daily for 5 days	Useful for lower-tract infection when susceptible; avoid at or beyond 37 weeks of pregnancy, during labor/imminent labor, with lactation, in newborns younger than 1 month, and with CrCl less than 60 mL/min.
urinary-analgesics	Phenazopyridine	Symptom relief only; teach expected orange urine and temporary contact-lens staining risk.
anticholinergics	Hyoscyamine	Can reduce bladder spasm/urgency discomfort; monitor for retention-prone adverse effects.
analgesics	nsaids (NSAIDs), acetaminophen	Use for flank-pain symptom control while monitoring renal and GI safety context.

Clinical Judgment Application

Clinical Scenario

A pregnant patient presents with dysuria and urinary frequency; urinalysis shows white blood cells and nitrites, and later reports fever with flank discomfort.

• Recognize Cues: Lower UTI symptoms, positive urinalysis markers, progression to systemic signs.
• Analyze Cues: Clinical picture may be evolving from cystitis toward pyelonephritis.
• Prioritize Hypotheses: Highest priority is upper UTI in pregnancy with maternal-fetal risk.
• Generate Solutions: Obtain urine culture, start appropriate antimicrobial therapy, and escalate for possible inpatient management.
• Take Action: Coordinate urgent provider evaluation and monitor hydration, fever, and pain.
• Evaluate Outcomes: Symptoms improve, culture-directed therapy is completed, and no progression to severe renal complication occurs.

Related Concepts

• Urinary Tract Infections - Lower urinary tract bladder infection subtype.
• Urinary Tract Infections - Lower urinary tract urethral inflammation with infectious and noninfectious causes.
• Urinary Tract Infections - Upper urinary tract infection with systemic risk.
• bladder-assessment - Correct specimen technique improves diagnostic accuracy.
• bladder-assessment - Often observed without treatment except in pregnancy-focused management pathways.
• urinary-anti-infectives - Drug-class safety distinctions for nitrofurantoin, TMP-SMX, fosfomycin, and methenamine pathways.
• cauti-prevention-and-catheter-necessity-review - Daily indication review and catheter-sparing practice reduce device-associated UTI burden.
• sepsis - Escalation pathway when urinary infection becomes systemic.

Self-Check

1. Which symptom combination most strongly suggests progression from lower UTI to pyelonephritis?
2. Why is urine culture prioritized early in pregnancy even without symptoms?
3. Which medication teaching point for nitrofurantoin and phenazopyridine is most important for safety?